Sales and Marketing

Showing 15 posts of 11528 posts found.

Hep-B vaccine four-year battle for FDA approval is finally won

November 10, 2017 Medical Communications, Sales and Marketing biotech, drugs, dynavax, hepatitis B, pharma, pharmaceutical

Dynavax had said it was the last throw of the dice for its hepatitis B vaccine, Hepislav-B – the data …

Sanofi signs $805 million deal for MS drug

November 10, 2017 Medical Communications, Sales and Marketing Principia Biopharma, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi has decided to build its pipeline in neurological disorders with the agreement to develop Principia Biopharma’s BTK inhibitor candidate …

Recipharm to end operations in two facilities in Sweden

November 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm today announces that it will initiate a process with the intention of discontinuing manufacturing operations at its facilities in …

NHS England seals access deals with big pharma for breast cancer and MS

November 9, 2017 Sales and Marketing Cancer, Mavenclad, Merck, NHS, NHS England, NICE, Perjeta, Roche, Simon Stevens, breast cancer, multiple sclerosis

NHS England has entered into a commercial agreement with Merck which aims to provide access to innovative treatments for both …

The End Game: Payer Engagement Webinar

November 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, pharma, pharmaceutical

In our latest free to attend webinar, we have joined up with NDA to bring you the latest market access …

FDA expands Roche drug indication to approve first-ever treatment for rare blood cancer

November 7, 2017 Manufacturing and Production, Sales and Marketing Cancer, Erdheim-Chester Disease, FDA, Roche, blood cancer, pharma

The FDA has announced the approval of Roche’s Zelboraf (vemurafenib) in the treatment of Erdheim-Chester Disease (ECD), expanding its already …

Takeda’s dengue vaccine surpasses Sanofi’s in P2 trial

November 7, 2017 Manufacturing and Production, Sales and Marketing Sanofi, Takeda, biotech, drugs, pharma, pharmaceutical

Sanofi spent more than $1.5 billion and two decades to develop the first ever vaccine for dengue fever, only a …

Valeant backs away from female libido pill

November 7, 2017 Manufacturing and Production, Sales and Marketing Addyi, Valeant, biotech, drugs, pharma, pharmaceutical

Only two years ago, Valeant was so keen to get involved with a pill reported to increase the female libido …

Clinical trial transparency: Letting the light in

November 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, clinical trial transparency, clinical trials, drugs, pharma, pharmaceutical

Transparency is one of those words for which the exact meaning has become clouded by murkier connotations. The chances are …

Merck KGaA posts promising osteoarthritis data

November 6, 2017 Research and Development, Sales and Marketing Merck KGaA, biotech, drugs, pharma, pharmaceutical

Merck KGaA’s share price is 7% down over the course of the year – a year that, on the pharmaceutical …

Valeant begins long comeback trail with FDA approval

November 6, 2017 Sales and Marketing Valeant, Vyzulta, biotech, drugs, pharma, pharmaceutical

Valeant has had precious little to be happy about over the last few years, it’s bounced from one piece of …

Gut bacteria may be key to efficacy of immunotherapies

November 6, 2017 Research and Development, Sales and Marketing biotech, drugs, immunotherapy, pharma, pharmaceutical

Why immunotherapies are successful in some individuals and not in others is a matter of huge importance to both patients …

NHS to offer GP appointments via smartphone

November 6, 2017 Medical Communications, Sales and Marketing GP at hand, NHS, biotech, drugs, pharma, pharmaceutical

It has been announced that I trial will begin in London offering the public GP consultations through their smartphone. The …
The Gateway to Local Adoption Series

Latest content